Abstract
Eleven novel chalcone analogs having a 2-phenylimino-3-phenylthiazolidin-4-one core structure were designed, synthesized and investigated for cytotoxicity against murine B16 and L1210 cancer cells. Single crystal X-ray structure analyses confirmed that these chalcone analogs adopt a Z-geometry about the alkene bond. One of the compounds, 3j, which possesses a 2-chloro-5-bromo substitution in the phenyl moiety, showed moderate cytotoxicity against murine (B16) and human melanoma (MDA-MB-435) cell lines with an IC50 value of 57 and 12 µ M, respectively. At 30 µ M, compound 3j had virtually no effects on the microtubules in A10 cells.
Keywords: Chalcones, 2-Phenylimino-3-phenylthiazolidin-4-one, Cytotoxicity, Tubulin, murine (B16), melanoma, Single crystal X-ray structure analyses, antimalarial, Thiazolidinone, antischistosomal agents, phenylimine substituents, S. epidermidis, MTT assay, antimitotic agents
Letters in Drug Design & Discovery
Title: Design, Synthesis and Cytotoxicity of Chalcone Analogs Derived from 2-Phenylimino-3-phenylthiazolidin-4-one
Volume: 8 Issue: 8
Author(s): Vijay Satam, Ravi Kumar Bandi, Ajaya Kumar Behera, Bijay Kumar Mishra, Olivia Brockway, Samuel Tzou, Matthias Zeller, Moses Lee and Hari Pati
Affiliation:
Keywords: Chalcones, 2-Phenylimino-3-phenylthiazolidin-4-one, Cytotoxicity, Tubulin, murine (B16), melanoma, Single crystal X-ray structure analyses, antimalarial, Thiazolidinone, antischistosomal agents, phenylimine substituents, S. epidermidis, MTT assay, antimitotic agents
Abstract: Eleven novel chalcone analogs having a 2-phenylimino-3-phenylthiazolidin-4-one core structure were designed, synthesized and investigated for cytotoxicity against murine B16 and L1210 cancer cells. Single crystal X-ray structure analyses confirmed that these chalcone analogs adopt a Z-geometry about the alkene bond. One of the compounds, 3j, which possesses a 2-chloro-5-bromo substitution in the phenyl moiety, showed moderate cytotoxicity against murine (B16) and human melanoma (MDA-MB-435) cell lines with an IC50 value of 57 and 12 µ M, respectively. At 30 µ M, compound 3j had virtually no effects on the microtubules in A10 cells.
Export Options
About this article
Cite this article as:
Satam Vijay, Bandi Ravi Kumar, Behera Ajaya Kumar, Mishra Bijay Kumar, Brockway Olivia, Tzou Samuel, Zeller Matthias, Lee Moses and Pati Hari, Design, Synthesis and Cytotoxicity of Chalcone Analogs Derived from 2-Phenylimino-3-phenylthiazolidin-4-one, Letters in Drug Design & Discovery 2011; 8(8) . https://dx.doi.org/10.2174/157018011796576033
DOI https://dx.doi.org/10.2174/157018011796576033 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Fanconi Anemia Proteins, DNA Interstrand Crosslink Repair Pathways, and Cancer Therapy
Current Cancer Drug Targets Plant Natural Products in Anticancer Drug Discovery
Current Organic Chemistry Recent Developments in the Regulation of Monoamine Oxidase Form and Function: Is the Current Model Restricting Our Understanding of the Breadth of Contribution of Monoamine Oxidase to Brain [dys]Function?
Current Topics in Medicinal Chemistry Deregulation of the Akt Pathway in Human Cancer
Current Cancer Drug Targets Protective Effect of Metformin, Resveratrol and Alpha-lipoic Acid on Radiation- Induced Pneumonitis and Fibrosis: A Histopathological Study
Current Drug Research Reviews Neurovascular Mechanisms of Hypertension in Pregnancy
Current Neurovascular Research The Role of P-Glycoprotein in Psychiatric Disorders: A Reliable Guard of the Brain?
Central Nervous System Agents in Medicinal Chemistry NRF2-Dependent Glutamate-L-Cysteine Ligase Catalytic Subunit Expression Mediates Insulin Protection Against Hyperglycemia-Induced Brain Endothelial Cell Apoptosis
Current Neurovascular Research Antioxidants in the Practice of Medicine; What Should the Clinician Know?
Cardiovascular & Hematological Disorders-Drug Targets Molecular Bases of Liver Cancer Refractoriness to Pharmacological Treatment
Current Medicinal Chemistry Immune Responses to Lentiviral Vectors
Current Gene Therapy Immunotherapy for Prostate Cancer
Current Pharmaceutical Design Immunogenicity and Tumorigenicity of Pluripotent Stem Cells and their Derivatives: Genetic and Epigenetic Perspectives
Current Stem Cell Research & Therapy Galectin-9 in Cancer Therapy
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Anthocyanins As Modulators of Cell Redox-Dependent Pathways in Non-Communicable Diseases
Current Medicinal Chemistry Editorial [Hot Topic: Cancer Biomarkers Guest Editor: Robert C. Rees]
Current Cancer Therapy Reviews The Current and Future Therapies for Human Osteosarcoma
Current Cancer Therapy Reviews Long Term Cardiovascular Risk in Women
Vascular Disease Prevention (Discontinued) Drug Targeting to the Brain - A Review
Current Nanoscience Polyketide Natural Products, Acetogenins from Graviola (Annona muricata L), its Biochemical, Cytotoxic Activity and Various Analyses Through Computational and Bio-Programming Methods
Current Pharmaceutical Design